Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionKennedy Capital Management, Inc.
Latest Disclosed Ownership91,264 shares
Latest Disclosed Value $ 12,719,464
Kennedy Capital Management, Inc. reports 4.34% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 13, 2026 - Kennedy Capital Management, Inc. filed a 13F-HR form disclosing ownership of 91,264 shares of Gilead Sciences, Inc. (CH:GILD) valued at $12,719,464 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 95,403 shares of Gilead Sciences, Inc.. This represents a change in shares of -4.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F Gilead Sciences COM 375558103 91,264 -4,139 -4.34 12,719 8.63 0.2694
2026-02-13 2025-12-31 13F Gilead Sciences COM 375558103 95,403 1,128 1.20 11,710 11.90 0.2480
2025-11-13 2025-09-30 13F Gilead Sciences COM 375558103 94,275 15,234 19.27 10,465 19.41 0.2313
2025-08-13 2025-06-30 13F Gilead Sciences COM 375558103 79,041 -41 -0.05 8,763 -1.11 0.2089
2025-05-13 2025-03-31 13F Gilead Sciences COM 375558103 79,082 -3,931 -4.74 8,861 15.57 0.2117
2025-02-13 2024-12-31 13F Gilead Sciences COM 375558103 83,013 16,603 25.00 7,668 37.72 0.1703
2024-11-14 2024-09-30 13F Gilead Sciences COM 375558103 66,410 5,023 8.18 5,568 32.20 0.1229
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 61,387 21,167 52.63 4,212 42.94 0.0900
2024-05-15 2024-03-31 13F Gilead Sciences COM 375558103 40,220 40,220 2,946 0.0606
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.